New patent for Astellas drug XTANDI

Annual Drug Patent Expirations for XTANDI Xtandi is a drug marketed by Astellas and is included in two NDAs. It is available from one supplier. There are three patents protecting…

The post New patent for Astellas drug XTANDI appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog